MagForce AG Publishes its First Shareholder Letter 2016

MagForce AG Publishes its First Shareholder Letter 2016

MagForce USA has also made significant progress toward adapting NanoTherm(TM) therapy as a focal treatment for prostate cancer. Our NanoTherm(TM) therapy for the focal treatment of prostate cancer is viewed as a very promising complement to current …

(Visited 1 times, 1 visits today)
3
Like
Save

Comments

Comments are disabled for this post.